Related Experiment Video
Updated: Jun 21, 2026

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
Household airborne Penicillium associated with peak expiratory flow variability in asthmatic children
Kemp W Bundy1, Janneane F Gent, William Beckett
1Department of Medicine, Division of Allergy/Immunology & Rheumatology, University of Rochester Medical Center, Rochester, New York 14642, USA. Kemp_Bundy@urmc.rochester.edu
Background:
Exposure to airborne fungi has been associated with increased airway hyperreactivity and asthma prevalence.
Objective:
To investigate the association between common indoor fungi and airway hyperreactivity measured by peak expiratory flow variability in asthmatic children.
Methods:
Children 6 to 12 years of age (n = 225) with a physician diagnosis of asthma were enrolled in the study to have their peak expiratory flow recorded twice daily during a 2-week period. Genus-specific, quantitative, in-home airborne mold concentrations were measured. Logistic regression models were used to examine the relationship between a mean peak expiratory flow variability greater than 18.5% (75th percentile) and any mold in the home (total mold, Cladosporium, Penicillium, Aspergillus, and Alternaria).
Results:
Mold was detected in 93% of the homes. The most common molds were Cladosporium in 72% and Penicillium in 42% of the samples. Controlling for sex, ethnicity, age, and winter season of sampling, Penicillium measured in the home was associated with a mean peak expiratory flow variability greater than 18.5% (odds ratio, 2.4; 95% confidence interval, 1.2-4.8). Greater peak expiratory flow variability was not associated with total mold or other mold measured in the home.
Conclusion:
Exposure to airborne Penicillium is associated with increased peak expiratory flow variability in asthmatic children.
Related Concept Videos
Asthma I: Introduction
Asthma III: Clinical Manifestations
Asthma-I: Introduction
Inhaled Medications
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-III: Symptoms and Complications
Classification of Asthma

